课题基金 / 基金详情

项目摘要

项目成果

Stephanie Duggins Davis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overarching goals of the Genetic Disorders of Mucociliary Clearance Consortium (GDMCC) Administrative Core is to provide comprehensive and sustained administrative, logistical, and operational support for all investigators, team members, trainees, and our patient advocacy groups. These goals will lead to successful completion of projects that will advance our understanding of the genetic bases, pathophysiology and clinical course of rare, chronic suppurative respiratory disease, specifically primary ciliary dyskinesia and primary immunodeficiencies; improve diagnostic capabilities; and identify novel therapeutic targets and endpoints for clinical trials that will ultimately improve outcomes for these affected individuals. The specific aims of the Administrative Core are: 1) To provide excellent and comprehensive operational and organizational administration of the Consortium; 2) Mandate and facilitate regular, meaningful communications and coordination between all collaborating investigators and institutions; 3) Establish and maintain strong, productive working relationships with collaborators, patient and stakeholder groups, the NIH and serve as a point of coordination with the biostatisticians, Rare Diseases Clinical Research Network and the Data Management and Coordinating Center; 4) Ensure and promote awareness of the GDMCC to the clinical, scientific, and relevant patient and stakeholder communities; and 5) Recruit and regularly communicate with an External Advisory Committee consisting of scientific, clinical, and patient-stakeholder representatives. By achieving these aims, the GDMCC will successfully continue to improve the outcomes of patients with primary ciliary dyskinesia and primary immunodeficiencies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pediatrics & Pulmonary Network: Improving Health Together
  • 批准号:
    10469209
  • 项目类别:
  • 资助金额:
    $3.0万
  • 财政年份:
    2022
  • 负责人:
    Stephanie Duggins Davis
  • 依托单位:
Viral Pathogenesis of Early Cystic Fibrosis Lung Disease
Viral Pathogenesis of Early Cystic Fibrosis Lung Disease
Viral Pathogenesis of Early Cystic Fibrosis Lung Disease
海外基金